Decursin from Angelica gigas Nakai Blocks hKv1.5 Channel

  • Kwak, Yong-Geun (Department of Pharmacology, Chonbuk National University Medical School, Institute for Medical Research) ;
  • Choi, Bok-Hee (Department of Pharmacology, Chonbuk National University Medical School, Institute for Medical Research) ;
  • Kim, Dae-Keun (College of Pharmacy, Woosuk University) ;
  • Eun, Jae-Soon (College of Pharmacy, Woosuk University)
  • Received : 2010.10.14
  • Accepted : 2010.12.22
  • Published : 2011.01.31


Decursin was purified from Angelica gigas Nakai, and its effects on the human Kv1.5 (hKv1.5) currents were recorded in mouse fibroblasts ($Ltk^-$ cells) by whole-cell patch-clamp technique. Decursin inhibited hKv1.5 current in a concentration-dependent manner, with an $IC_{50}$ value of $2.7\;{\mu}M$ at +60 mV. Decursin accelerated the inactivation kinetics of the hKv1.5 channel, and slowed the deactivation kinetics of the hKv1.5 current, resulting in a tail crossover phenomenon. Also, decursin inhibited the hKv1.5 current in a use-dependent manner. These results strongly suggest that decursin is a kind of open-channel blocker of the hKv1.5 channel.


  1. Choe, H., Lee, Y. K., Lee, Y. T., Choe, H., Ko, S. H., Joo, C. U., Kim, M. H., Kim, G. S., Eun, J. S., Kim, J. H., Chae, S. W. and Kwak, Y. G. (2003) Papaverine blocks hKv1.5 channel current and human atrial ultrarapid delayed rectifier $K^+$ currents. J. Pharmacol. Exp. Ther. 304, 706-712.
  2. Chung, S. S., Blackshear, J. L., Shen, W. K., Hammill, S. C. and Gersh, B. J. (2001) Epidemiology and natural history of atrial fibrillation: clinical implications. J. Am. Coll. Cardiol. 37, 371-378.
  3. Eun, J. S., Choi, B. H., Park, J. A., Lee, G. I., Lee, T. Y., Kim, D. K., Jung, Y. H., Yoo, D. J. and Kwak, Y. G. (2005a) Open channel block of hKv1.5 by psoralen from Heracleum moellendorffii Hance. Arch. Pharm. Res. 28, 269-273.
  4. Eun, J, S., Kim, K. S., Kim, H. N., Park, S. A., Ma, T. Z., Lee, K. A., Kim, D. K., Kim, H. K., Kim, I. S., Jung, Y. H., Zee, O. P., Yoo, D. J. and Kwak, Y. G. (2007) Synthesis of psoralen derivatives and their blocking effect of hKv1.5 channel. Arch. Pharm. Res. 30, 155-160.
  5. Eun, J. S., Park, J. A., Choi, B. H., Cho, S. K., Kim, D. K. and Kwak, Y. G. (2005b) Effects of oxypeucedanin on hKv1.5 and action potential duration. Biol. Pharm. Bull. 28, 657-660.
  6. Fedida, D., Chen, F. S. and Zhang, X. (1998) The 1997 Stevenson Award Lecture. Cardiac $K^+$ channel gating: cloned delayed rectifier mechanisms and drug modulation. Can. J. Physiol. Pharmacol. 76, 77-89.
  7. Jung, D. J., Porzel, A. and Huneck, S. (1991) Gigasol and other coumarines from Angelica gigas. Phytochemistry 30, 710-712.
  8. Kang, S. Y., Lee, K. Y., Sung, S. H., Park, M. J. and Kim, Y. C. (2001) Coumarins isolated from Angelica gigas inhibit acetyl cholinesterase: Structure-activity relationships. J. Nat. Prod. 64, 683-685.
  9. Kim, W. J., Lee, S. J., Choi, Y. D. and Moon, S. K. (2010) Decursin inhibits growth of human bladder and colon cancer cells via apoptosis, G1-phase cell cycle arrest and extracellular signal-regulated kinase activation. Int. J. Mol. Med. 25, 635-641.
  10. Kwak, Y. G., Kim, D. K., Ma, T. Z., Park, S. A., Park, H., Jung, Y. H., Yoo, D. J. and Eun, J. S. (2006) Torilin from Torilis japonica (Houtt.) DC. blocks hKv1.5 channel current. Arch. Pharm. Res. 29, 834-839.
  11. Kwak, Y. G., Navarro-Polanco, R. A., Grobaski, T., Gallagher, D. J. and Tamkun, M. M. (1999) Phosphorylation is required for alteration of Kv1.5 K+ channel function by the Kvbeta 1.3 subunit. J. Biol. Chem. 274, 25355-25361.
  12. Lee, H. J., Lee, H. J., Lee, E. O., Lee, J. H., Lee, K. S., Kim, K. H., Kim, S. H. and Lu, J. (2009) In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin. Am. J. Chin. Med. 37, 127-142.
  13. Lee, S., Kang, S. S. and Shin, K. H. (2002) Coumarins and a pyrimidine from Angelica gigas roots. Nat. Prod. Sci. 8, 58-61.
  14. Lee, S. H., Lee, Y. S., Jung, S. H., Shin, K. H., Kim, B. K. and Kang, S. S. (2003) Anti-tumor activities of decursinol angelate and decursin from Angelica gigas. Arch. Pharm. Res. 26. 727-730.
  15. Pachaly, P., Treitner, A. and Sin, K. S. (1996) Neue cumaringlykoside aus Angelica gigas. Pharmazie 51, 57-61.
  16. Perchenet, L. and Clement-Chomienne, O. (2000) Characterization of mibefradil block of the human heart delayed rectifi er hKv1.5. J. Pharmacol. Exp. Ther. 295, 771-778.
  17. Ryu, K. S., Hong, N. D., Kim, N. J. and Kong, Y. Y. (1990) Studies on the coumarin constituents of the root of Angelica gigas Nakai. Isolation of decursinol angelate and assay of decursin angelate and decursin. Korean J. Pharmcacogn. 21, 64-68.
  18. Shin, K. H., Han, J. M. and Lee, I. R. (1996) Effect of the constituents of Angelica gigantis Radix on hepatic drug metabolizing enzymes. Korean J. Pharmcacogn. 27, 323-327.
  19. Snyders, D. J., Tamkun, M. M. and Bennett, P. B. (1993) A rapidly activating and slowly inactivating potassium channel cloned from human heart. Functional analysis after stable mammalian cell culture expression. J. Gen. Physiol. 101, 513-543.
  20. Wang, Z., Fermini, B. and Nattel, S. (1994) Rapid and slow components of delayed rectifi er current in human atrial myocytes. Cardiovasc. Res. 28, 1540-1546.
  21. Yook, C. S. (1990) Coloured medicinal plants of Korea. pp. 390. Academy Book, Seoul, Korea.